Monarch Partners Asset Management LLC Ironwood Pharmaceuticals Inc Transaction History
Monarch Partners Asset Management LLC
- $328 Million
- Q4 2022
A detailed history of Monarch Partners Asset Management LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 276,579 shares of IRWD stock, worth $531,031. This represents 1.04% of its overall portfolio holdings.
Number of Shares
276,579
Previous 303,550
8.89%
Holding current value
$531,031
Previous $3.15 Million
8.93%
% of portfolio
1.04%
Previous 0.94%
Shares
3 transactions
Others Institutions Holding IRWD
# of Institutions
240Shares Held
161MCall Options Held
11.2MPut Options Held
19.2K-
Black Rock Inc. New York, NY22.9MShares$43.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$37.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$31.5 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$22.5 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$18.2 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $294M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...